Host defense peptides as new weapons in cancer treatment

Cellular and Molecular Life Sciences

Volumn 62, Issue 7-8, 2005, Pages 784-790

  Papo, N ^a   Shai, Y ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Amphipatic peptides; Anticancer peptides; Antimicrobial peptides; Cytolytic peptides; Host defense peptides; Lytic peptides; Membrane permeabilization; Model membranes

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 8; CECROPIN; CISPLATIN; CYTARABINE; CYTOCHROME C; DEATH RECEPTOR; DEFENSIN; DOXORUBICIN; ETOPOSIDE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; FLUOROURACIL; MAGAININ 2; MAGAININ DERIVATIVE; MELITTIN; MSI 238; PEPTIDE DERIVATIVE; TACHYPLESIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ASCITES; CANCER CELL; CANCER CHEMOTHERAPY; CELL MEMBRANE; DRUG POTENCY; DRUG POTENTIATION; EUKARYOTE; GENE EXPRESSION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LEUKEMIA P 388; MELANOMA; MITOCHONDRIAL MEMBRANE; MULTIDRUG RESISTANCE; NECROSIS; NONHUMAN; OVARY TUMOR; PROKARYOTE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; CELL MEMBRANE PERMEABILITY; DEFENSINS; DRUG RESISTANCE, MULTIPLE; HUMANS; MICE; MITOCHONDRIA; NEOPLASMS; PHOSPHATIDYLSERINES;

EUKARYOTA; PROKARYOTA;

EID: 18544366816     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-005-4560-2     Document Type: Review

References (86)

1. Smith L. L., Brow K., Carthew P., Lim C. K., Martin E. A., Styles J. et al. (2000) Chemoprevention of breast cancer by tamoxifen: risks and opportunities. Crit. Rev. Toxicol. 30: 571-594
2. Garnier-Suillerot, A. Marbeuf-Gueye C., Salerno M., Loetchutinat C., Fokt I., Krawczyk M. et al. (2001) Analysis of drug transport kinetics in multidrug-resistant cells: implications for drug action. Curr. Med. Chem. 8: 51-64
3. Dunn G. P., Bruce A. T., Ikeda H., Old L. J. and Schreiber R. D. (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3: 991-998
4. Mocellin S., Rossi C. R. and Nitti D. (2004) Cancer vaccine development: on the way to break immune tolerance to malignant cells. Exp. Cell Res. 299: 267-278
5. Shadidi M. and Sioud M. (2003) Selective targeting of cancer cells using synthetic peptides. Drug Resist. Updat. 6: 363-371
6. Leuschner, C. and Hansel, W. (2004) Membrane disrupting lytic peptides for cancer treatments. Curr. Pharm. Des. 10: 2299-2310
7. Papo N., Shahar M., Eisenbach L. and Shai Y. (2003) A novel lytic peptide composed of D, L amino acids selectively kills cancer cells in culture and in mice. J. Biol. Chem. 278: 21018-21023
8. Boman H. G. (1995) Peptide antibiotics and their role in innate immunity. Annu. Rev. Immun. 13: 61-92
9. Breukink E. and de Kruijff B. (1999) The lantibiotic nisin, a special case or not? Biochim. Biophys. Acta 1462: 223-234
10. Dimarcq J. L., Bulet P., Hetru C. and Hoffmann J. (1998) Cysteine-rich antimicrobial peptides in invertebrates. Biopolymers 47: 465-477
11. Shai Y. (1999) Mechanism of the binding, insertion and destabilisation of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides [Review]. Biochim. Biophys. Acta 1462: 55-70
12. Tossi A., Sandri L. and Giangaspero A. (2000) Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55: 4-30
13. Steiner H., Andreu D. and Merrifield R. B. (1988) Binding and action of cecropin and cecropin analogues: antibacterial peptides from insects. Biochim. Biophys. Acta 939: 260-266
14. Matsuzaki K., Harada M., Handa T., Funakoshi S., Fujii N., Yajima H. et al. (1989) Magainin 1-induced leakage of entrapped calcein out of negatively-charged lipid vesicles. Biochim. Biophys. Acta 981: 130-134
15. Pouny Y., Rapaport D., Mor A., Nicolas P. and Shai Y. (1992) Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry 31: 12416-12423
16. Gazit E., Lee W. J., Brey P. T. and Shai Y. (1994) Mode of action of the antibacterial cecropin B2: a spectrofluorometric study. Biochemistry 33: 10681-10692
17. Ganz T. and Lehrer R. I. (1998) Antimicrobial peptides of vertebrates. Curr. Opin. Immunol. 10: 41-44
18. Simmaco M., Mignogna G. and Barra D. (1998) Antimicrobial peptides from amphibian skin: what do they tell us? Biopolymers 47: 435-450
19. Zasloff M. (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395
20. Nicolas P. and Mor A. (1995) Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu. Rev. Microbiol. 49: 277-304
21. Hancock R. E. and Diamond G. (2000) The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8: 402-110
22. Brotz, H and Sahl H. G. (2000) New insights into the mechanism of action of lantibiotics-diverse biological effects by binding to the same molecular target. J. Antimicrob. Chemother. 46: 1-6
23. Steiner H., Hultmark D., Engstrom A., Bennich H. and Boman H. G. (1981) Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 292: 246-248
24. Chen H. M., Wang W., Smith D. and Chan S. C. (1997) Effects of the anti-bacterial peptide cecropin B and its analogs, cecropins B-1 and B-2, on liposomes, bacteria and cancer cells. Biochim. Biophys. Acta 1336: 171-179
25. Zasloff M. (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA 84: 5449-5453
26. Baker M. A., Maloy W. L., Zasloff M. and Jacob L. S. (1993) Anticancer efficacy of Magainin2 and analogue peptides. Cancer Res. 53: 3052-3057
27. Cruciani R. A., Barker J. L., Zasloff M., Chen H. C. and Colamonici O. (1991) Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc. Natl. Acad. Sci. USA 88: 3792-3796
28. Rozek T., Wegener K. L., Bowie J. H., Olver I. N., Carver J. A., Wallace J. C. et al. (2000) The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2. Eur. J. Biochem. 267: 5330-5341
29. Papo N., Oren Z., Pag U., Sahl H. G. and Shai Y. (2002) The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. J. Biol. Chem. 277: 33913-33921
30. Habermann E. and Jentsch J. (1967) Hoppe Seyler's Z. Physiol. Chem. 348: 37-50
31. Mai J. C., Mi Z., Kim S. H., Ng B. and Robbins P. D. (2001) A proapoptotic peptide for the treatment of solid tumors. Cancer Res. 61: 7709-7712
32. Andreu D. and Rivas L. (1998) Animal antimicrobial peptides: an overview. Biopolymers 47: 415-433
33. Lichtenstein A., Ganz T., Selsted M. E. and Lehrer R. I. (1986) In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood 68: 1407-10.
34. Vizioli J. and Salzet M. (2002) Antimicrobial peptides versus parasitic infections? Trends Parasitol. 18: 475-476
35. Bulet P., Hetru C., Dimarcq J. L. and Hoffmann D. (1999) Antimicrobial peptides in insects; structure and function. Dev. Comp. Immunol. 23: 329-344
36. Frohm M., Agerberth B., Ahangari G., Stahle-Backdahl M., Liden S., Wigzell H. et al. (1997) The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272: 15258-15263
37. Johansson J., Gudmundsson G. H., Rottenberg M. E., Berndt K. D. and Agerberth B. (1998) Conformation-dependent antibacterial activity of the naturally-occuring human peptide LL-37. J. Biol. Chem. 273: 3718-3724
38. Papo N. and Shai Y. (2003) New lytic peptides based on the D, L amphipathic helix motif preferentially kill tumor cells compared to nornal cells. Biochemistry 42: 9346-9354
39. Shin S. Y., Kang S. W., Lee D. G., Eom S. H., Song W. K. and Kim J. I. (2000) CRAMP analogues having potent antibiotic activity against bacterial, fungal and tumor cells without hemolytic activity. Biochem. Biophys. Res. Commun. 275: 904-909
40. Srisailam S., Arunkumar A. I., Wang W., Yu C. and Chen H. M. (2000) Conformational study of a custom antibacterial peptide cecropin B1: implications of the lytic activity. Biochim. Biophys. Acta 1479: 275-285
41. Ellerby H. M., Arap W., Ellerby L. M., Kain R., Andrusiak R., Rio G. D. et al. (1999) Anti-cancer activity of targeted proapoptotic peptides. Nat. Med. 5: 1032-1038
42. Lehrer R. I. and Ganz T. (1999) Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol. 11: 23-27
43. Shai Y. (2002) Mode of action of membrane active antimicrobial peptides. Biopolymers 66: 236-248
44. Hoffmann J. A., Kafatos F. C., Janeway C. A. and Ezekowitz R. A. (1999) Phylogenetic perspectives in innate immunity. Science 284: 1313-1318
45. Hendrich A. B. and Michalak K. (2003) Lipids as a target for drugs modulating multidrug resistance of cancer cells. Curr. Drug Targets 4: 23-30
46. Papo N. and Shai Y. (2003) Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes? Peptides 24: 1693-1703
47. Verkleij A. J., Zwaal R. F., Roelofsen B., Comfurius P., Kastelijn D. and Deenen L. V. (1973) The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim. Biophys. Acta 323: 178-193
48. Zwaal R. F. and Schroit A. J. (1997) Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89: 1121-1132
49. Cappelli G., Paladini S, and D'Agata A. (1999) Tumor markers in the diagnosis of pancreatic cancer. Tumori 85: S19-21.
50. Chan S. C., Hui L. and Chen H. M. (1998) Enhancement of the cytolytic effect of anti-bacterial cecropin by the microvilli of cancer cells. Anticancer Res. 18: 4467-4474
51. Wade D., Boman A., Wahlin B., Drain C. M., Andreu D., Boman H. G. et al. (1990) All-D amino acid-containing channel-forming antibiotic peptides. Proc. Natl. Acad. Sci. USA 87: 4761-4765
52. Bessalle R., Kapitkovsky A., Gorea A., Shalit I. and Fridkin M. (1990) All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett. 274: 151-155
53. Merrifield R. B., Juwadi P., Andreu D., Ubach J., Boman A. and Boman H. G. (1995) Retro and retroenantio analogs of cecropin-melittin hybrids. Proc. Natl. Acad. Sci. USA 92: 3449-3453
54. Hetru C., Letellier L., Oren Z., Hoffmann J. A. and Shai Y. (2000) Androctonin, a hydrophilic disulphide-bridged non-haemolytic anti-microbial peptide: a plausible mode of action. Biochem. J. 345: 653-664
55. Oren Z. and Shai Y. (1998) Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers 47: 451-463
56. Papo N. and Shai Y. (2003) Exploring peptide membrane interaction using surface plasmon resonance: differentiation between pore formation versus membrane disruption by lytic peptides. Biochemistry 42: 458-466
57. Matsuzaki K., Murase O. and Miyajima K. (1995) Kinetics of pore formation by an antimicrobial peptide, magainin 2, in phospholipid bilayers. Biochemistry 34: 12553-12559
58. Ludtke S. J., He K., Heller W. T., Harroun T. A., Yang L. and Huang, H. W. (1996) Membrane pores induced by magainin. Biochemistry 35: 13723-13728
59. Ehrenstein G. and Lecar H. (1977) Electrically gated ionic channels in lipid bilayers. Q. Rev. Biophys. 10: 1-34
60. Vogel H., Jahnig F., Hoffmann V. and Stumpel J. (1983) The orientation of melittin in lipid membranes. A polarized infrared spectroscopy study. Biochim. Biophys. Acta 733: 201-209
61. Shai Y., Bach D. and Yanovsky A. (1990) Channel formation properties of synthetic pardaxin and analogues. J. Biol. Chem. 265: 20202-20209
62. Shai Y. and Oren Z. (1996) Diastereoisomers of cytolysins, a novel class of potent antibacterial peptides. J. Biol. Chem. 271: 7305-7308
63. Li H., Kolluri S. K., Gu J., Dawson M. I., Cao X., Hobbs P. D. et al. (2000) Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 289: 1159-1164
64. Cory S. and Adams J. M. (1998) Matters of life and death: programmed cell death at Cold Spring Harbor. Biochim. Biophys. Acta 1377: R25-44
65. Pardo J., Perez-Galan P., Gamen S., Marzo I., Monleon I., Kaspar A. A. et al. (2001) A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis. J. Immunol. 167: 1222-1229
66. Chen, Y. Xu X., Hong S., Chen J., Liub N., Underhill C. B. et al. (2001) RGD-tachyplesin inhibits tumor growth. Cancer Res. 61: 2434-2438
67. Park N. G., Lee S., Oishi O., Aoyagi H., Iwanaga S., Yamashita S. et al. (1992) Conformation of tachyplesin I from Tachypleus tridentatus when interacting with lipid matrices. Biochemistry 31: 12241-12247
68. Kaufmann S. H. and Earnshaw W. C. (2000) Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256: 42-49
69. Rasmussen H. R. J. E. (1990), vol. 31, Horecker B. L., Stadtman E. R., Chock P. B. and Levitski A., eds, pp. 1-98, Academic Press, San Diego
70. Sharma S. V. (1992) Melittin resistance: a counterselection for ras transformation. Oncogene 7: 193-201
71. Wachinger M., Kleinschmidt A., Winder D., von Pechmann N., Ludvigsen A., Neumann M. et al. (1998) Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J. Gen. Virol. 79: 731-740
72. Winder D., Gunzburg W. H., Erfle V. and Salmons B. (1998) Expression of antimicrobial peptides has an antitumour effect in human cells. Biochem. Biophys. Res. Commun. 242: 608-612
73. Chernysh S., Kim S. I., Bekker G., Pleskach V. A., Filatova N. A., Anikin, V. B. et al. (2002) Antiviral and antitumor peptides from insects. Proc. Natl. Acad. Sci. USA 99: 12628-12632
74. Peck M. K., Darveau R. P. and Fell H. P. (1993) Identification of serum components that inhibit the tumoricidal activity of amphiphilic alpha helical peptides. Cancer Chemother. Pharmacol. 32: 109-115
75. Papo N., Braunstein A., Eshhar Z. and Shai Y. (2004) Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino acid peptide: membrane lysis, increased necrosis and inhibition of prostate-specific antigen secretion. Cancer Res. 64: 5779-5786
76. Hui L., Leung K. and Chen H. M. (2002) The combined effects of antibacterial peptide cecropin A and anti-cancer agents on leukemia cells. Anticancer Res. 22: 2811-2816
77. Ohsaki Y., Gazdar A. F., Chen H. C. and Johnson B. E. (1992) Antitumor activity of magainin analogues against human lung cancer cell lines. Cancer Res. 52: 3534-3538
78. Lincke C. R., van der Bliek A. M., Schuurhuis G. J., van der Velde-Koerts T., Smit J. J. and Borst P. (1990) Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA. Cancer Res. 50: 1779-1785
79. Vogel H. and Jahnig F. (1986) The structure of melittin in membranes. Biophys. J. 50: 573-582
80. Beschiaschvili G. and Seelig J. (1990) Melittin binding to mixed phosphatidylglycerol/phosphatidylcholine membranes. Biochemistry 29: 52-58
81. Schwarz G., Gerke H., Rizzo V. and Stankowski S. (1987) Incorporation kinetics in a membrane, studied with the pore-forming peptide alamethicin. Biophys. J. 52: 685-692
82. Pawlak M., Kuhn A. and Vogel H. (1994) Pf3 coat protein forms voltage-gated ion channels in planar lipid bilayers. Biochemistry 33: 283-290
83. Marsh D. (1996) Peptide models for membrane channels. Biochem. J. 315: 345-361
84. Matsuzaki K., Murase O., Fujii N. and Miyajima K. (1995) Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. Biochemistry 34: 6521-6526
85. Ladokhin A. S. and White S. H. (2001) 'Detergent-like' permeabilization of anionic lipid vesicles by melittin. Biochim. Biophys. Acta 1: 253-260
86. Pouny Y. and Shai Y. (1992) Interaction of D-amino acid incorporated analogues of pardaxin with membranes. Biochemistry 31: 9482-9490